| Jennifer Lynn Anspach, CCC-SLP | |
|
315 N French Ave, Arlington, WA 98223-1317 | |
| (360) 618-6200 | |
| Not Available |
| Full Name | Jennifer Lynn Anspach |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 315 N French Ave, Arlington, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790269934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL60609301 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Lynn Anspach, CCC-SLP 1777 S Burlington Blvd # 211, Burlington, WA 98233-3223 Ph: (207) 650-2447 | Jennifer Lynn Anspach, CCC-SLP 315 N French Ave, Arlington, WA 98223-1317 Ph: (360) 618-6200 |
News Archive
Cantel Medical Corp., announced today the launch of a new, unique design of medical face masks - the SecureFit™ series by Crosstex International, a Cantel subsidiary and a leading U.S. manufacturer of medical face masks. The SecureFit™ series of masks addresses scientific research that points to poorly fitting masks as a major hindrance to their effectiveness.
PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that the initial abstract for the investigator-sponsored clinical study of its RenalGuard System(TM) has been published, in advance of the annual meeting of the European Society of Cardiology, August 29 - September 2, 2009 in Barcelona, Spain, on the ESC website.
Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes.
Groundbreaking enzyme research could revolutionise the way drugs are made and have major implications for the industrial sector, including brewing, food processing, domestic cleaning and paper manufacturing.
› Verified 3 days ago
David Alexander Icanberry, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16710 Smokey Point Blvd Ste 402, Arlington, WA 98223 Phone: 360-363-4234 Fax: 360-363-4235 | |
Kaylee Ingraham, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 505 E 3rd St, Arlington, WA 98223 Phone: 253-549-6171 | |
Mr. Brenda Jean Leighton, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19105 44th Ave Ne, Arlington, WA 98223 Phone: 425-422-9312 | |
Mr. Philip L Karlberg, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 N French Ave, Arlington, WA 98223 Phone: 360-618-6252 Fax: 360-618-6221 | |
Ms. Anna Catherine Sullivan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 Hazel St, Arlington, WA 98223 Phone: 360-403-8247 | |
Bailey Protzeller, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 620 Hazel St, Arlington, WA 98223 Phone: 360-403-8247 | |
Mrs. Alison Claire Bartlett, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8213 Eaglefield Dr, Pioneer Elementary School, Arlington, WA 98223 Phone: 360-618-6230 |